CVS Health (NYSE:CVS) Stock Rating Lowered by StockNews.com

CVS Health (NYSE:CVS) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued to investors on Thursday.

A number of other equities analysts have also commented on CVS. Wells Fargo & Company decreased their price target on shares of CVS Health from $61.00 to $60.00 and set an “equal weight” rating on the stock in a report on Monday, November 4th. Truist Financial increased their price objective on CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research report on Friday, October 11th. UBS Group upped their target price on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $72.44.

CVS Health Stock Down 3.4 %

Shares of NYSE CVS opened at $53.19 on Thursday. The business’s fifty day moving average price is $59.32 and its 200-day moving average price is $58.76. CVS Health has a one year low of $52.71 and a one year high of $83.25. The stock has a market capitalization of $66.93 billion, a PE ratio of 13.50, a P/E/G ratio of 0.93 and a beta of 0.55. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company’s revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the company earned $2.21 earnings per share. On average, equities research analysts anticipate that CVS Health will post 5.48 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Orion Portfolio Solutions LLC raised its stake in CVS Health by 5.2% during the first quarter. Orion Portfolio Solutions LLC now owns 82,922 shares of the pharmacy operator’s stock valued at $6,614,000 after buying an additional 4,132 shares during the last quarter. M&G Plc purchased a new stake in CVS Health during the 1st quarter valued at about $62,454,000. Te Ahumairangi Investment Management Ltd increased its stake in CVS Health by 1.9% during the 1st quarter. Te Ahumairangi Investment Management Ltd now owns 116,942 shares of the pharmacy operator’s stock valued at $9,327,000 after purchasing an additional 2,180 shares in the last quarter. Nicolet Advisory Services LLC raised its holdings in CVS Health by 8.1% in the first quarter. Nicolet Advisory Services LLC now owns 11,083 shares of the pharmacy operator’s stock worth $813,000 after buying an additional 827 shares during the last quarter. Finally, Spirepoint Private Client LLC purchased a new stake in shares of CVS Health during the first quarter valued at approximately $225,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.